Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TH1I
|
||||
| Former ID |
DNC010796
|
||||
| Drug Name |
4-(6-phenyl-2,4'-bipyridin-4-yl)phenol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H16N2O
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=C3C=CC(=O)C=C3)C=C(N2)C4=CC=NC=C4
|
||||
| InChI |
1S/C22H16N2O/c25-20-8-6-16(7-9-20)19-14-21(17-4-2-1-3-5-17)24-22(15-19)18-10-12-23-13-11-18/h1-15,24H
|
||||
| InChIKey |
BOJKQAHFVITZEU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase I | Target Info | Inhibitor | [1] | |
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2010 May 1;18(9):3066-77. Epub 2010 Mar 27.Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.